Application | Comment | Organism |
---|---|---|
medicine | SMS2 is a potential therapeutic target for treatment of atherosclerosis | Mus musculus |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
ceramide + phosphatidylcholine | Mus musculus | - |
sphingomyelin + 1,2-diacyl-sn-glycerol | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mus musculus | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
macrophage | - |
Mus musculus | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
ceramide + phosphatidylcholine | - |
Mus musculus | sphingomyelin + 1,2-diacyl-sn-glycerol | - |
? |
Synonyms | Comment | Organism |
---|---|---|
SMS2 | - |
Mus musculus |
sphingomyelin synthase 2 | - |
Mus musculus |
General Information | Comment | Organism |
---|---|---|
malfunction | SMS2 deficiency causes significant induction of cholesterol efflux in vitro and in vivo, SMS2 deficiency in the macrophages reduces atherosclerosis in mice | Mus musculus |